EnGeneIC Competitors and Similar CompaniesClear all

EnGeneIC's competitors and similar companies include Genelux, SOTIO, Elpis Biopharmaceuticals and Amunix Pharmaceuticals.

	EnGeneIC EnGeneIC is a biopharmaceutical company focused on developing its proprietary EDV nanocell platform.	Genelux Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform.	SOTIO SOTIO is a biotechnology company that develops therapies focusing on the treatment of cancer.	Elpis Biopharmaceuticals Elpis Biopharmaceuticals is a company developing biological and cellular therapeutics for difficult-to-treat cancers.	Amunix Pharmaceuticals Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology.
Founding Date	Founding Date 2001	Founding Date 2001	Founding Date 2010	Founding Date 2017	Founding Date 2006
Type	Type Private	Type Public	Type Private	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech oncology pharma platform	Tags Healthcare biotech drug development oncology pharma platform	Tags Healthcare biotech oncology pharma platform therapy	Tags Healthcare biotech oncology pharma platform	Tags Healthcare biotech drug development oncology pharma platform
Locations	Locations Lane Cove West, AU HQ New York, US	Locations Thousand Oaks, US HQ	Locations CZ HQ Moskva, RU Basel, CH Boston, US	Locations Lexington, US HQ	Locations South San Francisco, US HQ
Employees	Employees 43	Employees 157% increase	Employees 218	Employees 12	Employees 42
Funding
Latest funding round	Latest funding round $ 150k (about 9 years ago)	Latest funding round N/A	Latest funding round $ 300k (about 9 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 21.1m	Total funding raised N/A	Total funding raised $ 300k	Total funding raised N/A	Total funding raised $ 190m